Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Vivasinvestigations-procedures-and-technology

Paeds Vivas · investigations-procedures-and-technology

Point-of-care glucose, ketone and urinalysis testing — branching viva

A branching viva following one scenario through the three core paediatric point-of-care tests: the capillary blood glucose meter and its inaccuracy in the neonate from the high haematocrit and the galactose or maltose interference with the glucose dehydrogenase strips, the blood beta-hydroxybutyrate ketone meter as the preferred measure over the urine acetoacetate in diabetic ketoacidosis with the ISPAD thresholds, and the urine dipstick with the leukocyte esterase and nitrite performance and the rule that the dipstick screens and the culture confirms. The candidate must defend the choice of test, the confirmation step, and the falsely reassuring results.

branching clinical structured oral
On this page & tools

Target exams

RACP General PaediatricsRACP DWERACP DCERCPCH Progress+MRCPCH ClinicalABP General PediatricsACGME PediatricsRCPSC Pediatrics

Target exams

RACP General PaediatricsRACP DWERACP DCERCPCH Progress+MRCPCH ClinicalABP General PediatricsACGME PediatricsRCPSC Pediatrics
Prompt
A five-year-old with known type 1 diabetes arrives vomiting and breathless with a glucose meter reading of 24 mmol per litre. The examiner releases information in stages and probes the candidate on the glucose meter chemistry and the neonatal limitations, the blood beta-hydroxybutyrate over the urine ketone with the ISPAD diagnostic thresholds, and the urine dipstick performance in the febrile infant including the lower nitrite sensitivity and the screen-versus-culture principle.

Branching viva — point-of-care glucose, ketone and urinalysis testing

The examiner releases the stem and then branches into four probes. A strong candidate names the test chemistry, defends the confirmation step, applies the ISPAD thresholds without prompting, and recognises the falsely reassuring results that this topic is built to prevent. [6] [10]

Opening (examiner)

"A five-year-old with known type 1 diabetes arrives vomiting and breathless. The bedside glucose meter reads 24 mmol per litre. Walk me through the point-of-care tests you would use and their limitations." [1]

Branch 1 — The glucose meter chemistry and the neonatal limitation (expected answer)

The capillary blood glucose meter measures the whole-blood glucose by the glucose oxidase or the glucose dehydrogenase electrochemical strip on the capillary sample, and it reports the result in five seconds in the millimoles per litre. The glucose oxidase reaction depends on the oxygen, which is the source of the oxygen interference, and the glucose dehydrogenase pyrroloquinoline-quinone variant cross-reacts with the galactose, the maltose, and the xylose. In the older child the meter is reliable, but in the neonate the high haematocrit, the variable oxygen, and the galactose or maltose interference bias the reading in either direction, so any critical or unexpected capillary glucose in a neonate is confirmed with the laboratory plasma glucose. [6] [7]

Probe. "The whole-blood glucose reads approximately ten to twelve per cent lower than the plasma glucose — why?" — The red cells contain less glucose than the plasma, so the whole-blood value sits below the plasma value, and the high neonatal haematocrit widens this bias. The device may report a whole-blood or a plasma-calibrated value, and the clinician must know which. [7]

Branch 2 — The blood beta-hydroxybutyrate over the urine ketone (expected answer)

The first confirmatory test after the glucose of 24 is the blood beta-hydroxybutyrate ketone meter. The beta-hydroxybutyrate is the predominant ketone in the diabetic ketoacidosis, produced at a three-to-one to ten-to-one ratio over the acetoacetate, and the blood ketone meter measures it directly through the beta-hydroxybutyrate dehydrogenase reaction. It reflects the current metabolic state and falls with the insulin therapy to track the resolution. The urine pad measures the acetoacetate, lags behind the blood value, and can paradoxically rise during the recovery as the beta-hydroxybutyrate converts to the acetoacetate. The blood ketone is therefore the preferred marker for the diagnosis and the monitoring. [1] [8]

Probe. "Give me the ISPAD 2022 diagnostic thresholds and the beta-hydroxybutyrate action bands." — The diabetic ketoacidosis is defined by the glucose greater than 11 mmol per litre, the venous pH under 7.3, the bicarbonate under 15, and the beta-hydroxybutyrate greater than 3. The severity is graded by the pH: the mild at 7.2 to 7.3, the moderate at 7.1 to 7.2, and the severe under 7.1. The beta-hydroxybutyrate is under 0.6 as the normal, 0.6 to 1.5 as the mild ketosis managed with the hydration and the sick-day plan, and over 3.0 with the acidosis as the ketoacidosis managed with the intravenous fluids and the insulin infusion. [1]

Branch 3 — The urine dipstick and the febrile infant (expected answer)

The urine dipstick screens for the urinary tract infection on the leukocyte esterase and the nitrite pads. The leukocyte esterase detects the esterases from the lysed neutrophils with a sensitivity of approximately 67 to 94 per cent. The nitrite uses the Griess reaction and has a high specificity of approximately 98 per cent but a low sensitivity of approximately 50 per cent, because the reaction needs the bladder dwell time for the nitrate conversion, and the young infant voids frequently. The combined both-negative dipstick carries the high negative predictive value that supports the rule-out in a well, low-risk child, but the dipstick does not replace the culture. [4] [5]

Probe. "The febrile non-toilet-trained infant has a positive leukocyte esterase — what is the next step?" — Obtain the culture from the catheterisation or the suprapubic aspiration before any antibiotic, because the dipstick is a screen and the culture confirms the infection. The adhesive bag specimen is unsuitable for the culture because of the high contamination rate, and the antibiotic may be started on the clinical probability while the culture grows. [2] [10]

Branch 4 — The falsely reassuring results (expected answer)

The five classic falsely reassuring results are the trust in a single neonatal glucose meter reading without the laboratory confirmation, the reassurance from the falling urine ketones during the recovery when the acetoacetate can rise, the exclusion of the urinary tract infection from a negative nitrite in the young infant, the diagnosis of the urinary tract infection from the dipstick alone, and the missing of the euglycaemic diabetic ketoacidosis when the glucose is under 11 but the ketone and the gas make the diagnosis. The general principle is that the bedside test is the first filter and the laboratory test is the arbiter, and the clinical condition of the child overrides both when they disagree.

[1] [6]

Probe. "Why might the glucose be under 11 in a child who still has diabetic ketoacidosis?" — The euglycaemic diabetic ketoacidosis occurs in the young or the partially treated child and the child who has had the reduced oral intake before the presentation. The diagnosis rests on the ketone and the blood gas, not on the glucose alone, and the bedside glucose meter should not be the sole criterion. [1]

Examiner's wrap

The three point-of-care tests give the rapid bedside answer that guides the first decision, but each has the known limitation that the confirmatory laboratory test must resolve. Hold the glucose meter chemistry and the neonatal confirmation rule, the blood beta-hydroxybutyrate thresholds and the reason it is preferred over the urine acetoacetate, and the dipstick performance with the lower nitrite sensitivity in the young infant and the screen-versus-culture principle. Treat the child rather than the number, and confirm the critical value before you act on it. [5] [8]

References

  1. [1]Glaser N, Kuppermann N, Yuen M, et al ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state Pediatric Diabetes, 2022.PMID 36250645
  2. [2]Subcommittee on Urinary Tract Infection, Roberts KB Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months Pediatrics, 2011.PMID 21873693
  3. [4]Gorelick MH, Shaw KN Screening tests for urinary tract infection in children: a meta-analysis Pediatrics, 1999.PMID 10545580
  4. [5]St John A, Boyd JC, Lowes AJ, Price CP The use of urinary dipstick tests to exclude urinary tract infection: a systematic review of the literature American Journal of Clinical Pathology, 2006.PMID 16880133
  5. [6]Raizman JE, Dearras L, Sikaria K, et al Clinical impact of improved point-of-care glucose monitoring in neonatal intensive care using Nova StatStrip: evidence for improved accuracy, better sensitivity, and reduced test utilization Clinical Biochemistry, 2016.PMID 27157715
  6. [7]Wada Y, Nakamura M, Mitsui M, et al Evaluation of two glucose meters and interference corrections for screening neonatal hypoglycemia Pediatrics International, 2015.PMID 25441549
  7. [8]Pulungan AB, Tridjaja B, Pulungan L, et al Diabetic ketoacidosis in adolescents and children: a prospective study of blood versus urine ketones in monitoring therapeutic response Acta Medica Indonesiana, 2018.PMID 29686175
  8. [10]Diviney J, Puar T, Ladhani S, et al Urine collection methods and dipstick testing in non-toilet-trained children Pediatric Nephrology, 2021.PMID 32918601